| Value | ₹1.33 Cr |
|---|
BSE filing, NSE: WIPRO. Summary written from the filing by ALFA Finder's alert engine.
Wipro Ltd: key numbers
- Share price
- ₹194.55
- Market cap
- ₹1,92,715 Cr
- Revenue (annual)
- ₹92,624 Cr
- Net profit (annual)
- ₹13,197 Cr
- P/E (TTM)
- 14.6×Sector 23.6×
- Promoter holding
- 72.58%-0.01% QoQ
- FII holding
- 9.46%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wipro Ltd
All →Wipro Employee Stock Options
Wipro allotted 95,503 equity shares under employee RSU and ESOP schemes. The allotment reflects routine employee share issuance with no stated consideration.
Wipro Other Announcement
Wipro's Designated Person Vinay Firake sold 2,00,000 ADRs worth Rs 4.07 Crore on 30 October 2026. Holding fell to 1,05,043 units.
- Value
- ₹4.07 Cr
Wipro Other Announcement
Wipro designated person Satyaki Banerjee sold 10,000 ADRs valued at about Rs 0.20 Crore, executed on NYSE. The filing is a Reg 7(2) PIT disclosure of this insider sale.
- Value
- ₹0.20 Cr
Wipro Other Announcement
Wipro disclosed a designated person's 34,200-share ADR sale worth about ₹0.67 Crore on 28 October 2026. The sale followed RSU exercise, leaving 60,266 securities held.
- Value
- ₹0.67 Cr
Wipro Acquisition Worth ₹0.02 Cr
Wipro's step-down subsidiary completed its acquisition of a 20% stake in FLARRE.AI on 28 Oct 2026. The transaction amount is Rs.0.02 Crore.
- Value
- ₹0.02 Cr
Wipro Acquisition
Wipro completed its 20% stake acquisition in FLARRE.AI, Inc. via Wipro IT Services, LLC on October 28, 2026. No deal value was disclosed.
Other other announcement announcements
All →Kansai Nerolac Paints Other Announcement
Kansai Nerolac authorised Pravin Chaudhari, Yash Ahuja and Rukmini Subramanian to determine material events from 1 December 2026. It only lists KMP and contact details.
Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.
Physicswallah Other Announcement
Physicswallah's IPO monitoring report flags a deviation from offer objects for the quarter ended September 30, 2026. The diverted funds were restored on October 30, 2026.
Gujarat Kidney and Super Speciality Other Announcement
Gujarat Kidney filed Brickwork's monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation from the IPO fund-utilisation objects.
PDS Other Announcement
PDS Limited submitted the CRISIL Ratings monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation in the utilisation of its QIP proceeds.